Y-Intercept (Hong Kong) Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1772875 HONG KONG, K3

Position in REGN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,994,080

-$3,807,421 QoQ

Shares Held

3,198

-69.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#515

of 1,322 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. REGN ranks #41 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	101,908	$10,865,430
2	MRNA	Moderna, Inc.	139,861	$9,794,465
3	BBIO	BridgeBio Pharma, Inc.	107,419	$8,000,567
4	AXSM	Axsome Therapeutics, Inc.	22,923	$5,610,862
5	IONS	Ionis Pharmaceuticals Inc	67,374	$5,342,084
6	ADMA	Adma Biologics, Inc.	573,581	$4,800,872
7	UPB	Upstream Bio, Inc.	693,555	$4,799,400
8	NRIX	Nurix Therapeutics, Inc.	192,434	$4,668,448

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,994,080	3,198	-69.0%	Shares	Sole	2026-07-14
2025-09-30	$5,801,501	10,318	-70.4%	Shares	Sole	2025-10-31
2025-06-30	$18,308,850	34,874	+259.4%	Shares	Sole	2025-08-01
2025-03-31	$6,154,567	9,704	-15.8%	Shares	Sole	2025-05-06
2024-12-31	$8,209,603	11,525	+22.3%	Shares	Sole	2025-02-04
2024-09-30	$9,907,937	9,425	+379.2%	Shares	Sole	2024-11-15
2024-03-31	$1,893,217	1,967	-38.2%	Shares	Sole	2024-05-10
2023-12-31	$2,797,353	3,185	+43.4%	Shares	Sole	2024-02-13
2023-06-30	$1,595,877	2,221	+100.6%	Shares	Sole	2023-08-14
2022-12-31	$798,689	1,107	+30.7%	Shares	Sole	2023-02-14
2022-06-30	$500,687	847	-54.4%	Shares	Sole	2022-08-08
2022-03-31	$1,296,965	1,857	-55.1%	Shares	Sole	2022-05-16
2021-09-30	$2,501,208	4,133	-1.7%	Shares	Sole	2021-11-15
2021-06-30	$2,349,219	4,206	—	Shares	Sole	2021-08-26
No filing history on record for this holder in this stock.